Related Experiment Video
Updated: Jan 27, 2026

In Vitro Ubiquitination and Deubiquitination Assays of Nucleosomal Histones
Published on: July 25, 2019
USP17 Suppresses Tumorigenesis and Tumor Growth through Deubiquitinating AEP
Xi Chen1, Chen Wang2, Keman Liao3
1CAS key laboratory of Tissue Microenvironment and Tumor, Shanghai Institute of Nutrition and Health, Shanghai Institutes for Biological Sciences, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai, 200025, China.
Abstract:
Ubiquitin-specific protease 17 (USP17), a novel member of deubiquitinase, is reported to play essential roles in several solid tumors. However, the expression and function of USP17 in breast cancer tumorigenesis remains ambiguity. Here we found that the mRNA level of USP17 was lower in breast cancer tissues than normal tissues. Meanwhile, higher USP17 level was detected in normal epithelial cell MCF-10A and a less-malignant cell MCF-7 than malignant cell line MDA-MB-231. Inhibition of USP17 in MCF7 cells enhanced tumorigenesis and tumor growth while overexpression of USP17 in malignant MDA-MB-231 cells reduced its tumorigenesis and growth ability in vitro and in vivo. Further study revealed that USP17 interacted with and deubiquitinated Asparaginyl endopeptidase (AEP), resulting in decreased protein levels of AEP. Moreover, knockdown of AEP inhibited breast cancer tumorigenesis and growth in vitro and in vivo through the inactivation of ERK signaling. Taken together, our works indicate that USP17 deubiquitinates AEP, down-regulates its protein level, and inhibits breast cancer tumorigenesis through disturbing ERK signaling. Thus, our data suggests that USP17 is a potential tumor suppressor in breast cancer and AEP is a promising target in breast cancer therapy.
Insights
Ubiquitin-specific protease 17 (USP17) acts as a tumor suppressor in breast cancer by deubiquitinating Asparaginyl endopeptidase (AEP), reducing its levels and inhibiting tumor growth via ERK signaling. This suggests USP17 as a therapeutic target.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Ubiquitin-specific protease 17 (USP17) is a deubiquitinase implicated in various solid tumors.
- The precise role of USP17 in breast cancer development remains unclear.
Purpose of the Study:
- To investigate the expression and function of USP17 in breast cancer.
- To elucidate the molecular mechanism by which USP17 influences breast cancer tumorigenesis.
Main Methods:
- Quantitative analysis of USP17 mRNA levels in breast cancer tissues and cell lines.
- In vitro and in vivo experiments involving USP17 inhibition and overexpression.
- Co-immunoprecipitation assays to identify USP17 interacting proteins.
- Western blotting to assess protein levels and signaling pathways (ERK).
Main Results:
- USP17 mRNA levels were lower in breast cancer tissues compared to normal tissues.
- USP17 expression inversely correlated with malignancy in breast cancer cell lines.
- USP17 inhibition promoted, while USP17 overexpression suppressed, breast cancer cell growth in vitro and in vivo.
- USP17 directly interacted with and deubiquitinated Asparaginyl endopeptidase (AEP), leading to reduced AEP protein levels.
- AEP knockdown inhibited breast cancer growth by inactivating ERK signaling.
Conclusions:
- USP17 functions as a tumor suppressor in breast cancer.
- USP17 inhibits breast cancer progression by deubiquitinating AEP, reducing its levels, and subsequently impacting ERK signaling.
- USP17 represents a potential therapeutic target, and AEP a promising therapeutic target in breast cancer treatment.
Related Concept Videos
Population Growth
Meristems and Plant Growth
Acid Suppressive Drugs for Peptic Ulcer Disease: Antacids
However, this neutralization reaction between...
Exponential Growth
Relationship Growth
Primary and Secondary Growth in Roots and Shoots

